Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
29.14
-0.26 (-0.88%)
Nov 12, 2026, 4:00 PM EST - Market closed
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $5.07 billion as of November 12, 2026. It is the 3,559th most valuable company in the world and the 1,155th biggest in the United States. Its market cap has increased by 6.53% in one year.
Market Cap
5.07B
Enterprise Value
4.52B
1-Year Change
6.53%
Global Rank
Country Rank
#1,155 United States
Category
ChartMarket Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $5.07B, an increase of 3,980.98%. That is a compound annual growth rate of 79.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 5.07B | -6.15% |
| Dec 31, 2025 | 5.40B | 527.16% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 6.30B |
| Ligand Pharmaceuticals | 6.28B |
| Veradermics | 6.20B |
| Mirum Pharmaceuticals | 6.16B |
| Scholar Rock Holding | 5.85B |
| Erasca | 5.41B |
| PTC Therapeutics | 5.36B |
| Edgewise Therapeutics | 5.09B |